Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas — Stephen Poitureau (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas
Shared by
Jean Yves Blay
Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas
Article
2025
en
Authors
+10 more
SP
Stephen Poitureau
MD
Marie‐Cécile Le Deley
MB
Mehdi Brahmi
Abstract
1 min read
This retrospective study does not support a link between high trabectedin RDI and PFS or OS for advanced L-sarcoma patients.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
76P Relative dose-intensity of trabectedin and outcome of advanced L-sarcomas
Stephen Poitureau
,
M. Le Deley
,
M. Brahmi
,
Emmanuelle Bompas
,
J.E. Kurtz
,
Simon Nannini
,
Christophe Perrin
,
Loïc Lebellec
,
Thomas Ryckewaert
,
Romain Ould-Ammar
,
Clémence Leguillette
,
Jean Yves Blay
,
N. Penel
Article
2024
89P IMmunotherapy response associated clinical and biological PREdictive factors in advanced SARComas: A retrospective multicenter study
Mina Fazel
,
Romain Varnier
,
Jean Yves Blay
,
Mehdi Brahmi
Dataset
Supplementary Table from Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study
Maud Toulmonde
,
Mehdi Brahmi
,
Antoine Giraud
,
Camille Chakiba
,
Alban Bessede
,
Michèle Kind
,
Émilie Toulza
,
Marina Pulido
,
Sabrina Albert
,
Jean-Philippe Guégan
,
Sophie Cousin
,
Simone Mathoulin‐Pélissier
,
Raul Perret
,
Sabrina Croce
,
Jean Yves Blay
,
Isabelle Ray‐Coquard
,
Anne Floquet
,
Antoîne Italiano
Dataset
Supplementary Table from Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study
Maud Toulmonde
,
Mehdi Brahmi
,
Antoine Giraud
,
Camille Chakiba
,
Alban Bessede
,
Michèle Kind
,
Émilie Toulza
,
Marina Pulido
,
Sabrina Albert
,
Jean-Philippe Guégan
,
Sophie Cousin
,
Simone Mathoulin‐Pélissier
,
Raul Perret
,
Sabrina Croce
,
Jean Yves Blay
,
Isabelle Ray‐Coquard
,
Anne Floquet
,
Antoîne Italiano
Preprint
2023
Supplementary Figure from Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study
Maud Toulmonde
,
Mehdi Brahmi
,
Antoine Giraud
,
Camille Chakiba
,
Alban Bessede
,
Michèle Kind
,
Émilie Toulza
,
Marina Pulido
,
Sabrina Albert
,
Jean-Philippe Guégan
,
Sophie Cousin
,
Simone Mathoulin‐Pélissier
,
Raul Perret
,
Sabrina Croce
,
Jean Yves Blay
,
Isabelle Ray‐Coquard
,
Anne Floquet
,
Antoîne Italiano
Discussion(0)
No comments yet. Be the first to comment.